# Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity

> **NCT04837183** · — · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 30 (actual)

## Conditions studied

- Ventricular Tachycardia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04837183
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-15
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** This study was closed before its planned primary completion date because early data indicated that VT ablation had little impact on sympathetic nerve activity in short-term follow up.
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04837183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04837183, "Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04837183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*